Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Neuropathy Pain Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Neuropathy Pain Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Calcium Channel Alpha 2-delta Ligands 1.4.3 Serotonin-norepinephrine Reuptake Inhibitors 1.4.4 Others 1.5 Market by Application 1.5.1 Global Neuropathy Pain Treatment Market Share by Application: 2020 VS 2026 1.5.2 Retail Pharmacies 1.5.3 Hospitals 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Neuropathy Pain Treatment Market Perspective (2015-2026) 2.2 Neuropathy Pain Treatment Growth Trends by Regions 2.2.1 Neuropathy Pain Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Neuropathy Pain Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Neuropathy Pain Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Neuropathy Pain Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Neuropathy Pain Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Neuropathy Pain Treatment Players by Market Size 3.1.1 Global Top Neuropathy Pain Treatment Players by Revenue (2015-2020) 3.1.2 Global Neuropathy Pain Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Neuropathy Pain Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Neuropathy Pain Treatment Market Concentration Ratio 3.2.1 Global Neuropathy Pain Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Neuropathy Pain Treatment Revenue in 2019 3.3 Neuropathy Pain Treatment Key Players Head office and Area Served 3.4 Key Players Neuropathy Pain Treatment Product Solution and Service 3.5 Date of Enter into Neuropathy Pain Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Neuropathy Pain Treatment Historic Market Size by Type (2015-2020) 4.2 Global Neuropathy Pain Treatment Forecasted Market Size by Type (2021-2026) 5 Neuropathy Pain Treatment Breakdown Data by Application (2015-2026) 5.1 Global Neuropathy Pain Treatment Market Size by Application (2015-2020) 5.2 Global Neuropathy Pain Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Neuropathy Pain Treatment Market Size (2015-2020) 6.2 Neuropathy Pain Treatment Key Players in North America (2019-2020) 6.3 North America Neuropathy Pain Treatment Market Size by Type (2015-2020) 6.4 North America Neuropathy Pain Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Neuropathy Pain Treatment Market Size (2015-2020) 7.2 Neuropathy Pain Treatment Key Players in Europe (2019-2020) 7.3 Europe Neuropathy Pain Treatment Market Size by Type (2015-2020) 7.4 Europe Neuropathy Pain Treatment Market Size by Application (2015-2020) 8 China 8.1 China Neuropathy Pain Treatment Market Size (2015-2020) 8.2 Neuropathy Pain Treatment Key Players in China (2019-2020) 8.3 China Neuropathy Pain Treatment Market Size by Type (2015-2020) 8.4 China Neuropathy Pain Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Neuropathy Pain Treatment Market Size (2015-2020) 9.2 Neuropathy Pain Treatment Key Players in Japan (2019-2020) 9.3 Japan Neuropathy Pain Treatment Market Size by Type (2015-2020) 9.4 Japan Neuropathy Pain Treatment Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Neuropathy Pain Treatment Market Size (2015-2020) 10.2 Neuropathy Pain Treatment Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Neuropathy Pain Treatment Market Size by Type (2015-2020) 10.4 Southeast Asia Neuropathy Pain Treatment Market Size by Application (2015-2020) 11 India 11.1 India Neuropathy Pain Treatment Market Size (2015-2020) 11.2 Neuropathy Pain Treatment Key Players in India (2019-2020) 11.3 India Neuropathy Pain Treatment Market Size by Type (2015-2020) 11.4 India Neuropathy Pain Treatment Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Neuropathy Pain Treatment Market Size (2015-2020) 12.2 Neuropathy Pain Treatment Key Players in Central & South America (2019-2020) 12.3 Central & South America Neuropathy Pain Treatment Market Size by Type (2015-2020) 12.4 Central & South America Neuropathy Pain Treatment Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Pfizer 13.1.1 Pfizer Company Details 13.1.2 Pfizer Business Overview and Its Total Revenue 13.1.3 Pfizer Neuropathy Pain Treatment Introduction 13.1.4 Pfizer Revenue in Neuropathy Pain Treatment Business (2015-2020)) 13.1.5 Pfizer Recent Development 13.2 Depomed 13.2.1 Depomed Company Details 13.2.2 Depomed Business Overview and Its Total Revenue 13.2.3 Depomed Neuropathy Pain Treatment Introduction 13.2.4 Depomed Revenue in Neuropathy Pain Treatment Business (2015-2020) 13.2.5 Depomed Recent Development 13.3 Eli Lilly 13.3.1 Eli Lilly Company Details 13.3.2 Eli Lilly Business Overview and Its Total Revenue 13.3.3 Eli Lilly Neuropathy Pain Treatment Introduction 13.3.4 Eli Lilly Revenue in Neuropathy Pain Treatment Business (2015-2020) 13.3.5 Eli Lilly Recent Development 13.4 Endo 13.4.1 Endo Company Details 13.4.2 Endo Business Overview and Its Total Revenue 13.4.3 Endo Neuropathy Pain Treatment Introduction 13.4.4 Endo Revenue in Neuropathy Pain Treatment Business (2015-2020) 13.4.5 Endo Recent Development 13.5 Grünenthal Group 13.5.1 Grünenthal Group Company Details 13.5.2 Grünenthal Group Business Overview and Its Total Revenue 13.5.3 Grünenthal Group Neuropathy Pain Treatment Introduction 13.5.4 Grünenthal Group Revenue in Neuropathy Pain Treatment Business (2015-2020) 13.5.5 Grünenthal Group Recent Development 13.6 Arbor Pharmaceuticals 13.6.1 Arbor Pharmaceuticals Company Details 13.6.2 Arbor Pharmaceuticals Business Overview and Its Total Revenue 13.6.3 Arbor Pharmaceuticals Neuropathy Pain Treatment Introduction 13.6.4 Arbor Pharmaceuticals Revenue in Neuropathy Pain Treatment Business (2015-2020) 13.6.5 Arbor Pharmaceuticals Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Neuropathy Pain Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Neuropathy Pain Treatment Revenue Table 3. Ranking of Global Top Neuropathy Pain Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Neuropathy Pain Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Calcium Channel Alpha 2-delta Ligands Table 6. Key Players of Serotonin-norepinephrine Reuptake Inhibitors Table 7. Key Players of Others Table 8. Global Neuropathy Pain Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Neuropathy Pain Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Neuropathy Pain Treatment Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Neuropathy Pain Treatment Market Share by Regions (2015-2020) Table 12. Global Neuropathy Pain Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Neuropathy Pain Treatment Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Neuropathy Pain Treatment Market Growth Strategy Table 18. Main Points Interviewed from Key Neuropathy Pain Treatment Players Table 19. Global Neuropathy Pain Treatment Revenue by Players (2015-2020) (Million US$) Table 20. Global Neuropathy Pain Treatment Market Share by Players (2015-2020) Table 21. Global Top Neuropathy Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropathy Pain Treatment as of 2019) Table 22. Global Neuropathy Pain Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Neuropathy Pain Treatment Product Solution and Service Table 25. Date of Enter into Neuropathy Pain Treatment Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Neuropathy Pain Treatment Market Size by Type (2015-2020) (Million US$) Table 28. Global Neuropathy Pain Treatment Market Size Share by Type (2015-2020) Table 29. Global Neuropathy Pain Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Neuropathy Pain Treatment Market Size Share by Application (2015-2020) Table 31. Global Neuropathy Pain Treatment Market Size by Application (2015-2020) (Million US$) Table 32. Global Neuropathy Pain Treatment Market Size Share by Application (2021-2026) Table 33. North America Key Players Neuropathy Pain Treatment Revenue (2019-2020) (Million US$) Table 34. North America Key Players Neuropathy Pain Treatment Market Share (2019-2020) Table 35. North America Neuropathy Pain Treatment Market Size by Type (2015-2020) (Million US$) Table 36. North America Neuropathy Pain Treatment Market Share by Type (2015-2020) Table 37. North America Neuropathy Pain Treatment Market Size by Application (2015-2020) (Million US$) Table 38. North America Neuropathy Pain Treatment Market Share by Application (2015-2020) Table 39. Europe Key Players Neuropathy Pain Treatment Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Neuropathy Pain Treatment Market Share (2019-2020) Table 41. Europe Neuropathy Pain Treatment Market Size by Type (2015-2020) (Million US$) Table 42. Europe Neuropathy Pain Treatment Market Share by Type (2015-2020) Table 43. Europe Neuropathy Pain Treatment Market Size by Application (2015-2020) (Million US$) Table 44. Europe Neuropathy Pain Treatment Market Share by Application (2015-2020) Table 45. China Key Players Neuropathy Pain Treatment Revenue (2019-2020) (Million US$) Table 46. China Key Players Neuropathy Pain Treatment Market Share (2019-2020) Table 47. China Neuropathy Pain Treatment Market Size by Type (2015-2020) (Million US$) Table 48. China Neuropathy Pain Treatment Market Share by Type (2015-2020) Table 49. China Neuropathy Pain Treatment Market Size by Application (2015-2020) (Million US$) Table 50. China Neuropathy Pain Treatment Market Share by Application (2015-2020) Table 51. Japan Key Players Neuropathy Pain Treatment Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Neuropathy Pain Treatment Market Share (2019-2020) Table 53. Japan Neuropathy Pain Treatment Market Size by Type (2015-2020) (Million US$) Table 54. Japan Neuropathy Pain Treatment Market Share by Type (2015-2020) Table 55. Japan Neuropathy Pain Treatment Market Size by Application (2015-2020) (Million US$) Table 56. Japan Neuropathy Pain Treatment Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Neuropathy Pain Treatment Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Neuropathy Pain Treatment Market Share (2019-2020) Table 59. Southeast Asia Neuropathy Pain Treatment Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Neuropathy Pain Treatment Market Share by Type (2015-2020) Table 61. Southeast Asia Neuropathy Pain Treatment Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Neuropathy Pain Treatment Market Share by Application (2015-2020) Table 63. India Key Players Neuropathy Pain Treatment Revenue (2019-2020) (Million US$) Table 64. India Key Players Neuropathy Pain Treatment Market Share (2019-2020) Table 65. India Neuropathy Pain Treatment Market Size by Type (2015-2020) (Million US$) Table 66. India Neuropathy Pain Treatment Market Share by Type (2015-2020) Table 67. India Neuropathy Pain Treatment Market Size by Application (2015-2020) (Million US$) Table 68. India Neuropathy Pain Treatment Market Share by Application (2015-2020) Table 69. Central & South America Key Players Neuropathy Pain Treatment Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Neuropathy Pain Treatment Market Share (2019-2020) Table 71. Central & South America Neuropathy Pain Treatment Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Neuropathy Pain Treatment Market Share by Type (2015-2020) Table 73. Central & South America Neuropathy Pain Treatment Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Neuropathy Pain Treatment Market Share by Application (2015-2020) Table 75. Pfizer Company Details Table 76. Pfizer Business Overview Table 77. Pfizer Product Table 78. Pfizer Revenue in Neuropathy Pain Treatment Business (2015-2020) (Million US$) Table 79. Pfizer Recent Development Table 80. Depomed Company Details Table 81. Depomed Business Overview Table 82. Depomed Product Table 83. Depomed Revenue in Neuropathy Pain Treatment Business (2015-2020) (Million US$) Table 84. Depomed Recent Development Table 85. Eli Lilly Company Details Table 86. Eli Lilly Business Overview Table 87. Eli Lilly Product Table 88. Eli Lilly Revenue in Neuropathy Pain Treatment Business (2015-2020) (Million US$) Table 89. Eli Lilly Recent Development Table 90. Endo Company Details Table 91. Endo Business Overview Table 92. Endo Product Table 93. Endo Revenue in Neuropathy Pain Treatment Business (2015-2020) (Million US$) Table 94. Endo Recent Development Table 95. Grünenthal Group Company Details Table 96. Grünenthal Group Business Overview Table 97. Grünenthal Group Product Table 98. Grünenthal Group Revenue in Neuropathy Pain Treatment Business (2015-2020) (Million US$) Table 99. Grünenthal Group Recent Development Table 100. Arbor Pharmaceuticals Company Details Table 101. Arbor Pharmaceuticals Business Overview Table 102. Arbor Pharmaceuticals Product Table 103. Arbor Pharmaceuticals Revenue in Neuropathy Pain Treatment Business (2015-2020) (Million US$) Table 104. Arbor Pharmaceuticals Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Global Neuropathy Pain Treatment Market Share by Type: 2020 VS 2026 Figure 2. Calcium Channel Alpha 2-delta Ligands Features Figure 3. Serotonin-norepinephrine Reuptake Inhibitors Features Figure 4. Others Features Figure 5. Global Neuropathy Pain Treatment Market Share by Application: 2020 VS 2026 Figure 6. Retail Pharmacies Case Studies Figure 7. Hospitals Case Studies Figure 8. Others Case Studies Figure 9. Neuropathy Pain Treatment Report Years Considered Figure 10. Global Neuropathy Pain Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Neuropathy Pain Treatment Market Share by Regions: 2020 VS 2026 Figure 12. Global Neuropathy Pain Treatment Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Neuropathy Pain Treatment Market Share by Players in 2019 Figure 15. Global Top Neuropathy Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropathy Pain Treatment as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Neuropathy Pain Treatment Revenue in 2019 Figure 17. North America Neuropathy Pain Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Neuropathy Pain Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Neuropathy Pain Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Neuropathy Pain Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Neuropathy Pain Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Neuropathy Pain Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Neuropathy Pain Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Pfizer Revenue Growth Rate in Neuropathy Pain Treatment Business (2015-2020) Figure 26. Depomed Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Depomed Revenue Growth Rate in Neuropathy Pain Treatment Business (2015-2020) Figure 28. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Eli Lilly Revenue Growth Rate in Neuropathy Pain Treatment Business (2015-2020) Figure 30. Endo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Endo Revenue Growth Rate in Neuropathy Pain Treatment Business (2015-2020) Figure 32. Grünenthal Group Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Grünenthal Group Revenue Growth Rate in Neuropathy Pain Treatment Business (2015-2020) Figure 34. Arbor Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Arbor Pharmaceuticals Revenue Growth Rate in Neuropathy Pain Treatment Business (2015-2020) Figure 36. Bottom-up and Top-down Approaches for This Report Figure 37. Data Triangulation Figure 38. Key Executives Interviewed

Pfizer Depomed Eli Lilly Endo Grünenthal Group Arbor Pharmaceuticals